Cargando…

Impact of BMI on Growth Hormone Stimulation Tests in Children and Adolescents: A Systematic Review and Meta-Analysis

Background: Peak stimulated growth hormone (GH) levels are known to decrease with increasing BMI, possibly leading to overdiagnosis of GH deficiency (GHD) in children with overweight and obesity. However, current guidelines do not provide guidance how to interpret peak GH values of these children, n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abawi, Ozair, Augustijn, Dieuwertje, Hoeks, Sanne, de Rijke, Yolanda B, van den Akker, Erica L T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266030/ http://dx.doi.org/10.1210/jendso/bvab048.1382

Ejemplares similares

OR14-2 Age of Onset of Obesity and Childhood BMI Trajectories in Rare Genetic Obesity Disorders
por: Brandsma, Annelies E, et al.
Publicado: (2022)

RF02 | PSAT110 Resting Energy Expenditure and Body Composition in Children and Adolescents with Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity
por: Abawi, Ozair, et al.
Publicado: (2022)

Cross‐sectional relation of long‐term glucocorticoids in hair with anthropometric measurements and their possible determinants: A systematic review and meta‐analysis
por: van der Valk, Eline, et al.
Publicado: (2021)

THU208 Predicting Treatment Quality Assessment Of Children With Congenital Adrenal Hyperplasia Using 24h Urine Metabolomics Profiling And A Machine Learning-assisted Approach
por: Abawi, Ozair, et al.
Publicado: (2023)

Growth Hormone Stimulation Testing Patterns Contribute to Gender Disparities in Growth Hormone Treatment
por: Kamoun, Camilia, et al.
Publicado: (2021)

THU207 11-oxygenated Androgens Are Strongly Associated With Treatment Quality In Children With Congenital Adrenal Hyperplasia Due To 21-Hydroxylase Deficiency
por: Abawi, Ozair, et al.
Publicado: (2023)

PSAT104 Predicting Response to Growth Hormone Therapy with Pituitary Volume and The Growth Hormone Stimulation Test
por: McGuirk, Liam, et al.
Publicado: (2022)

Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity
por: Abawi, Ozair, et al.
Publicado: (2022)

Impact of IGF-1 Normative Datasets on Indication and Outcome of Growth Hormone Stimulation Testing
por: de Bie, Prim, et al.
Publicado: (2021)

MON-113 The Effect of Body Mass Index on the Peak Growth Hormone Level After Growth Hormone Stimulation Test in Children with Short Stature
por: Lee, Nayeong, et al.
Publicado: (2020)

SAT-109 Utilizing Pituitary Volume (PV) and the Growth Hormone Stimulation Test (GHST) to Jointly Define the Etiology of Short Stature (SS): An Improved Diagnostic Criteria for Growth Hormone Treatment
por: Patale, Tara Prasanna, et al.
Publicado: (2020)

Diagnosis of Childhood and Adolescent Growth Hormone Deficiency Using Transcriptomic Data
por: Garner, Terence, et al.
Publicado: (2021)

SUN-256 Limited Usefulness of Single IGF-I Measurement as a Screening Test for Growth Hormone Deficiency in Children and Adolescents
por: Ibba, Anastasia, et al.
Publicado: (2019)

SUN-253 Effects of Growth Hormone Stimulation on the Immunologic Cellular Landscape in Pediatric Patients
por: Gujral, Jasmine, et al.
Publicado: (2019)

Growth Hormone Stimulation Testing: To Test or Not to Test? That Is One of the Questions
por: Yau, Mabel, et al.
Publicado: (2022)

MON-248 Impact of Body Mass Index on Peak Growth Hormone Response to Provocative Testing and Therapeutic Outcome in Children with Growth Hormone Deficiency
por: Yang, Aram, et al.
Publicado: (2019)

SUN-248 Growth Hormone Deficiency (GHD): Assessing Burden of Treatment in Children and Adolescents
por: Brod, Meryl, et al.
Publicado: (2019)

Long-Term Growth Hormone Therapy Does Not Advance Skeletal Maturation in Children and Adolescents
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2021)

The Relation Between Cortisol and Anthropometric Measurements Throughout Lifespan: A Systematic Review and Meta-Analysis
por: van der Valk, Eline S, et al.
Publicado: (2021)

THU172 Accuracy Of The Glucagon Testing In The Diagnosis Of Growth Hormone Deficiency During Transition
por: Di Iorgi, Natascia, et al.
Publicado: (2023)

SUN-281 Topiramate-Induced BMI Reduction in an Adolescent with Severe Obesity Associated with Classical Congenital Adrenal Hyperplasia
por: Seagroves, Amy, et al.
Publicado: (2019)

PMON313 Hyperinsulinemic Hypoglycemia and Growth Hormone Deficiency Secondary to 20p11 Deletion
por: Wee, Erica, et al.
Publicado: (2022)

Factors Driving Patient Preferences for Growth Hormone Treatment in Japanese Children With Growth Hormone Deficiency
por: Tanaka, Toshiaki, et al.
Publicado: (2021)

Primary Amenorrhea and Hyperandrogenism: Presenting Features of a Growth Hormone Producing Pituitary Adenoma in a Female Adolescent
por: Verma, Arushi, et al.
Publicado: (2021)

ODP392 Persistence with daily growth hormone treatment among pediatric patients with growth hormone deficiency in the UK
por: Loftus, Jane, et al.
Publicado: (2022)

ODP379 Brain MRIs may be value in children with isolated growth hormone deficiency whose peak GH level below 5 ng/mL in two growth hormone provocation test
por: Park, So Yun, et al.
Publicado: (2022)

THU173 Subanalysis By Tanner Stage In Phase 3 Trials In Children And Adolescents With Growth Hormone Deficiency Treated With Lonapegsomatropin
por: Hofman, Paul, et al.
Publicado: (2023)

OR17-4 Transcon Growth Hormone In The Treatment Of Pediatric Growth Hormone Deficiency: Results Of The Phase 3 Height Trial
por: Thornton, Paul, et al.
Publicado: (2019)

ODP386 Growth Velocity and Growth Hormone Deficiency During Puberty
por: Currais, Carolina, et al.
Publicado: (2022)

OR10-06 Somatrogon Growth Hormone in the Treatment of Pediatric Growth Hormone Deficiency: Results of the Pivotal Pediatric Phase 3 Clinical Trial
por: Deal, Cheri L, et al.
Publicado: (2020)

SAT-106 Growth Hormone Treatment Response in Children
por: Rath, Mitchell, et al.
Publicado: (2020)

SAT-102 Height Improvement with Recombinant Human Growth Hormone Therapy at Terminal Stage of Growth
por: Kim, Dae Hyun, et al.
Publicado: (2020)

SAT-108 Growth Hormone Deficiency in a Patient with Ectodermal Dysplasia
por: Alkhaled, Lina, et al.
Publicado: (2020)

Racial/Ethnic Disparities in the Investigation and Treatment of Pediatric Growth Hormone Deficiency
por: Hawkes, Colin Patrick, et al.
Publicado: (2021)

Isolated Growth Hormone Deficiency as a Cause of Hypoglycemia Past Infancy
por: Thakkar, Amruta, et al.
Publicado: (2021)

Economic Burden of Growth Hormone Deficiency in a US Pediatric Population
por: Kaplowitz, Paul B, et al.
Publicado: (2021)

FRI598 Evolving Growth Hormone Deficiency: A Proof Of Concept
por: Chimatapu, Sri Nikhita, et al.
Publicado: (2023)

OR10-05 Phase 3 FliGHt Trial: Experience of Switching from Daily Growth Hormone Therapy to Once-Weekly TransCon HGH in Children with Growth Hormone Deficiency
por: Maniatis, Aristides K, et al.
Publicado: (2020)

THU166 A Minimum Data Set For The Monitoring Of Recombinant Human Growth Hormone (rhGH) Therapy In Children With Growth Hormone Deficiency (GHD)—A GloBE-Reg Initiative
por: Chen, Suet Ching, et al.
Publicado: (2023)

THU177 Brain Magnetic Resonance Imaging Abnormalities And Effect On Growth Response In Children With Growth Hormone Deficiency
por: Choe, Jaewon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jel2blppagd3b960fp6vmlhif0